Stopping and restarting certain GLP-1 medications may affect their effectiveness. Many patients who stop taking these medications tend to restart them, with some studies suggesting that over half of those who stop will restart within a year. The potential side effects and outcomes of stopping and restarting GLP-1 medications are being explored, with some experts advising against the practice.